Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-11 Vance Terry Director Grant or award · Stock Option (right to buy) +20,000 20,000
2025-03-13 Vance Terry Director Grant or award · Stock Option (right to buy) +15,700 15,700
2024-03-06 Vance Terry Director Grant or award · Stock Option (right to buy) +15,700 15,700
2023-12-13 Vance Terry Director Sale −15,295 $9.12 $139K 5,800
2023-03-16 Vance Terry Director Option exercise +5,800 $14.00 $81K 21,095
2023-03-16 Vance Terry Director Option exercise · Stock Option (right to buy) −5,800 0
2023-03-02 Vance Terry Director Grant or award · Stock Option (right to buy) +10,800 10,800
2022-03-03 Vance Terry Director Grant or award · Stock Option (right to buy) +7,500 7,500
2021-03-02 Vance Terry Director Grant or award · Stock Option (right to buy) +7,500 7,500

Page 1 of 1 · 9 trades